Pharmx Technologies Limited · ASX:PHX
Pharmx Technologies — Microcap Investor Conference (October 2024)
24 slides from Pharmx Technologies's conference presentation, Oct 30, 2024
Slide 1: Investor Presentation
PharmX INVESTOR For personal use only PRESENTATION PHARMX TECHNOLOGIES LTD (ASX:PHX) Microcap Investor Conference CEO, Tom Culver 30 October 2024
Slide 2: Notice & Disclaimer
NOTICE & DISCLAIMER This presentation has been prepared by PharmX Technologies Limited (PharmX or the Although the Company believes that the expectations reflected in the forward-looking For personal use only Company or PHX). It should not be considered as an offer or invitation to subscribe for, st
Slide 3: Company Overview
COMPANY Overview For personal use only ASX Code PHX PharmX is a multi-access ordering EBITDA (underlying) $1.8m platform underpinned by advanced Share price 0.043c analytics designed to improve healthcare by driving growth and Cash at bank $4.8m efficiency across the pharmacy Shares on issue 598,506
Slide 4: FY24 Results
FY24 Results For personal use only $6.7m $1.8m $3.2m Growing Revenues Earnings Cash Position +9% on FY23 +13% on FY23 +2% on FY23 $6.25m $4.49m +20% Sale Proceeds Capital Return Platform Growth +20% MoM Marketplace Generating $4.6m net cash Distribution of 0.75c +4% YoY Gateway Per share (Dec ‘23)
Slide 5: FY24 HoH Financial Performance
FY24 HoH FINANCIAL Performance For personal use only $000's $000's $000's 7000 6,652 2000 7,000 2,000 1,827 500 500000 475 6000 6,000 400 400000 1500 1,500 5000 5,000 302 4000 4,000 3,417 1,080 300000 300 3,235 1000 1,000 3,000 3000 747 200000 200 173 2,000 2000 500 500 1,000 100000 100 1000 0 0 0 H
Slide 6: Q1 FY25 Financial Update
Q1 FY25 FINANCIAL Update For personal use only $1.89m Q1 FY25 94% Q1 FY25 5%Q1 FY25 Growing Revenues Marketplace Revenues Controlled Cost 4% ahead of budget Q1 revenue 94% of 5% better than budget ~14% above Q1 prior year FY24 full year revenue ~6% better v. Q1 prior year ~$700k H1 FY25 forecast $4.
Slide 7: For personal use only
The industry’s The most products For personal use only first choice in one place Our platform connects more ~80k unique SKUs. We are the pharmacists and suppliers than go-to provider for reach and any other; we’re relied upon range, saving time and energy daily to enable pharmacy trade. for all. 99%
Slide 8: Critical Infrastructure
CriticalINFRASTRUCTURE For personal use only 99% of Australian +20 POS & 140 Major Technology Pharmacies Intermediaries Suppliers Solutions Government *Indicative illustration of companies that PharmX operates with
Slide 9: Purpose
Purpose For personal use only To make a difference to healthcare by reimagining how the industry connects.
Slide 10: Competitive Advantages
COMPETITIVE Advantages For personal use only Whole-of- Unrivaled Digitisation and Extensive market industry consumer trend analytics and technology network tailwinds data We deliver high Supporting ~$20bn of The Australian pharmacy Visibility of entire availability, stable orders through the market
Slide 11: For personal use only
For personal use only Used by Over Approx Up to 99% 200m ~$19b 40 min of Australian order lines transacted of manual admin pharmacies transmitted annually annually saved per order Figures based on FY24 averages
Slide 12: Marketplace
MARKETPLACE For personal use only +353% +428% +329% Active users Total order value Repeat orders Year-on-year growth - YE June 2024
Slide 13: Analytics
ANALYTICS For personal use only Supplier Catalogue Automated Commercial insights repository replenishment & dashboards, alerts & product availability sales analytics
Slide 14: Technical Support, IT Services, Trade Marketing
For personal use only Technical Support IT Services Trade Marketing Australian-based tech Tailor-made solutions designed Partnership initiatives to support team. for unique business needs. fast-track growth. Service desk Integration Strategy Portal training engineering Content Integration support Be
Slide 15: The Growing Influence of Pharmacy
THE GROWING INFLUENCE OF Pharmacy For personal use only 1 in 3 70% 8CPA $5.2k OTC Australians of Australians Growing scope of Socio-cultural Broadening OTC consider believe pharmacists practice due to trends resulting in remit including pharmacists to be are the the most regulatory changes an increa
Slide 16: Accelerated by Demographic & Behavioral Trends
Accelerated BY DEMOGRAPHIC & BEHAVIORAL TRENDS For personal use only Growing population & Increased digitisation & shifting demographics shifting expectations Australia’s population is Tech-enabled workforce expansion Globally, B2B eCom is forecast to grow to 33.1m by and optimised workflows in reta
Slide 17: Strategy
Analytics Supplier Capability Growth Targeted increase in direct Increased market share suppliers across the boosts purchasing activity, PharmX network and generating richer data that through vertical For personal use only further enhances our integration as the driver of solutions, which in turn in
Slide 18: Supporting Initiatives
Sales led growth Increase total supplier base by 50% For personal use only Increase active accounts by 10% SUPPORTING Technology supported growth Initiatives Advance product solutions to support growth and increase engagement Analytics as a growth engine Commercialisation of high-value, bespoke repo
Slide 19: Investment Highlights
INVESTMENT Highlights For personal use only Dominant, independent with unrivaled network Strong strategic growth agenda supported by tailwinds and a well governed, expert team Unmatched awareness and customer satisfaction Advanced technology Unrivaled insights Strong balance sheet
Slide 20: Thank You
PharmX For personal use only THANK YOU investor.relations@pharmx.com.au Suite 11.02, Level 11,17 Castlereagh Street, Sydney 2000
Slide 21: Appendix
For personal use only APPENDIX
Slide 22: Leadership
LEADERSHIP Chairman Director Director Director For personal use only Nick England Jayne Shaw CFO (Acting) Sandy Mellis Jon Newbery PharmX has a robust governance Chief Executive Chief Technology Head of Marketing structure, guided by experts in Pharmacy, Officer Officer & Brand Product, Technology,
Slide 23: PharmX Overview: Gateway EDI
P H A R M X O V E R V I E W The PharmX Gateway is an EDI technology that helps pharmacies and suppliers exchange information quickly and accurately. For personal use only EDI stands for “electronic data interchange” - a technology used to transfer documents and information electronically between dif
Slide 24: Modernising Trade
P H A R M X O V E R V I E W MODERNISING Advanced checkout Fulfillment choice and multi supplier checkout. TRADE For personal use only Brand Exposure Increased brand opportunities through pharmacy-facing supplier ‘hubs’. Enriched Content Greater engagement with pharmacists through detailed product de
PharmX Technologies — Microcap Investor Conference (October 2024) on 6ix